SKI Market

A+| A| A-|

Indian Indices

Sensex

73,739.71 -367.14
( -0.50%)

Global Indices

Nasdaq

46,689.37 163.69
(0.35%)

Dow Jones

6,632.05 28.36
(0.43%)

Hang Seng

53,576.26 452.77
(0.85%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

92.68 -0.34
(-0.37%)

EUR-INR

106.73 -0.59
(-0.55%)

GBP-INR

122.22 -0.80
(-0.65%)

JPY-INR

0.58 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

369.1611632

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

36.3

77815.8

EPS(TTM)

Face Value()

Div & Yield %

36.91

Back

cie automotive india ltd

Daikaffil Chemicals India reports standalone net loss of Rs 1.34 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Daikaffil Chemicals India reported to Rs 1.34 crore in the quarter ended September 2025 as against net loss of Rs 0.58 crore during the previous quarter ended September 2024. Sales reported to Rs 6.04 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	6.04	0	0
OPM %	-21.03	0	-
PBDT	-1.26	-0.81	-56
PBT	-1.34	-0.87	-54
NP	-1.34	-0.58	-131

73,739.71 -367.14 ( -0.50%)

46,689.37 163.69 (0.35%)

6,632.05 28.36 (0.43%)

53,576.26 452.77 (0.85%)

10,436.29 71.50 (0.69%)

92.68 -0.34 (-0.37%)

106.73 -0.59 (-0.55%)

122.22 -0.80 (-0.65%)

0.58 0.00 (-0.50%)